Please Wait
Applying Filters...
menu
    • menu
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

    Virtual Booth

    Contact Supplier

    Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

    Virtual Booth

    Contact Supplier

    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Menu

    Zanubrutinib

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 48,900Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Prelude Therapeutics Presents Phase 1 Results of PRT2527 Study
    Prelude Therapeutics Presents Phase 1 Results of PRT2527 Study

    11 Dec 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/12/11/2995306/0/en/Prelude-Therapeutics-Presents-Preliminary-Results-of-Phase-1-Dose-escalation-Study-of-PRT2527-as-Monotherapy-and-in-Combination-with-Zanubrutinib-in-Patients-with-Relapsed-Refracto.html

    GLOBENEWSWIRE
    11 Dec 2024
    Share Share
    BeiGene Highlights Waldenström’s Macroglobulinemia At IWWM 2024
    BeiGene Highlights Waldenström’s Macroglobulinemia At IWWM 2024

    16 Oct 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20241016421498/en

    BUSINESSWIRE
    16 Oct 2024
    Share Share
    BeiGene Announces Updates to Commercial Leadership Team
    BeiGene Announces Updates to Commercial Leadership Team

    09 Sep 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240909481461/en

    BUSINESSWIRE
    09 Sep 2024
    Share Share
    BeiGene To Present BRUKINSA Plus Venetoclax CLL SLL Data
    BeiGene To Present BRUKINSA Plus Venetoclax CLL SLL Data

    14 Jun 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240614058364/en

    BUSINESSWIRE
    14 Jun 2024
    Share Share
    BeiGene & NewBridge Pharmaceuticals FZ LLC Mutually Agree to Conclude BRUKINSA
    BeiGene & NewBridge Pharmaceuticals FZ LLC Mutually Agree to Conclude BRUKINSA

    13 Jun 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240613697053/en

    BUSINESSWIRE
    13 Jun 2024
    Share Share
    Glenmark unit ties up with BeiGene to market cancer drugs in India
    Glenmark unit ties up with BeiGene to market cancer drugs in India

    21 May 2024

    // MONEYCONTROL

    https://www.moneycontrol.com/news/business/glenmark-unit-ties-up-with-beigene-to-market-cancer-drugs-in-india-12728111.html

    MONEYCONTROL
    21 May 2024
    Share Share